Acute coronary syndromes complicated by symptomatic and asymptomatic heart failure: does current treatment comply with guidelines? - 26/08/11
Doi : 10.1016/j.ahj.2003.11.014
Moti Haim, MD a, b, Alexander Battler, MD a, b, Solomon Behar, MD b, c, Paolo M Fioretti, MD d, Valentina Boyko, MSc c, Maarten L Simoons, MD e, David Hasdai, MD a, b, ⁎ 
a Cardiology Department, Rabin Medical Center, Petah-Tikva, Israel
b Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
c Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer, Israel
d Azienda Ospedaliera S. Maria della Misericordia, Udine, Italy
e Thoraxcentre, Rotterdam, The Netherlands
*Reprint requests: David Hasdai, MD, Cardiology Department, Rabin Medical Center, Beilinson Campus, 39 Jabotinsky St, Petah-Tikva 49100, Israel.
Mappa
 | Supported by Schering-Plough and Centocor. |
© 2004
Elsevier Inc. Tutti i diritti riservati.
Vol 147 - N° 5
P. 859-864 - Maggio 2004 Ritorno al numero
Articolo precedente
- ST-segment analyses and residual thrombi in the infarct-related artery: a report from the ASSENT PLUS ST-monitoring substudy
- Per Johanson, Lars Wallentin, Tage Nilsson, Lott Bergstrand, Bertil Lindahl, Mikael Dellborg
- Bleeding events with abciximab in acute coronary syndromes without early revascularization: an analysis of GUSTO IV–ACS
- Timo Lenderink, Eric Boersma, Witold Ruzyllo, Petr Widimsky, E.Magnus Ohman, Paul W Armstrong, Lars Wallentin, Maarten L Simoons, GUSTO IV-ACS Investigators
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?